Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
-1°
Mostly Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Anavex Lf SC
(NQ:
AVXL
)
8.180
-0.200 (-2.39%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 11, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Anavex Lf SC
< Previous
1
2
3
4
5
6
Next >
Why ReNew Energy Global Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
November 20, 2023
Shares of ReNew Energy Global Plc (NASDAQ: RNW) gained during Monday’s session following strong quarterly sales. ReNew Energy Global posted quarterly sales of $345.00 million, topping market estimates...
Via
Benzinga
Anavex Stock Is Moving Higher Monday: What's Going On?
November 20, 2023
Anavex Life Sciences Corp (NASDAQ: AVXL) shares are trading higher Monday.
Via
Benzinga
General Dynamics, Microsoft, Waste Management And Other Big Stocks Moving Higher On Wednesday
October 25, 2023
U.S. stocks traded lower, with the Nasdaq Composite falling more than 1% on Wednesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Preview: Anavex Life Sciences's Earnings
August 07, 2023
Via
Benzinga
The Latest Analyst Ratings for Anavex Life Sciences
May 02, 2023
Via
Benzinga
Analyst Ratings for Anavex Life Sciences
March 31, 2023
Via
Benzinga
Why Cutera Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Wednesday's Session
August 09, 2023
Gainers Tango Therapeutics, Inc. (NASDAQ: TNGX) climbed 85.2% to $7.09 after gaining 11% on Tuesday. Tango Therapeutics recently posted a narrower quarterly loss.
Via
Benzinga
This Short-Squeeze Candidate Could Actually Pan Out in the Long Run
February 09, 2023
Short-sellers have piled into this clinical-stage biopharma stock.
Via
The Motley Fool
Earnings Preview: Anavex Life Sciences
February 06, 2023
Via
Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth $3,000 Today
January 10, 2023
Via
Benzinga
Here's How Much $100 Invested In Anavex Life Sciences 5 Years Ago Would Be Worth Today
December 27, 2022
Via
Benzinga
Akamai Technologies, Array Technologies Music, HNI, PENN Entertainment And Other Big Stocks Moving Higher On Wednesday
August 09, 2023
U.S. stocks traded lower, with the Nasdaq Composite falling around 100 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Anavex Life Sciences Releases Encouraging Long Term Data From Rett Syndrome Study
June 28, 2023
Anavex Life Sciences Corp (NASDAQ: AVXL) announced that long-term clinical study results from the U.S.
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
May 26, 2023
Via
Benzinga
What's Going On With Anavex Life Sciences Shares Today?
March 30, 2023
Anavex Life Sciences Corp (NASDAQ: AVXL) shares are trading higher Thursday after the company reported results from its Phase 2 study in patients with Parkinson's disease dementia showing beneficial...
Via
Benzinga
Here's How Much You Would Have Made Owning Anavex Life Sciences Stock In The Last 5 Years
December 08, 2022
Via
Benzinga
Wall Street Thinks This Small-Cap Stock Can Quadruple in Value
March 15, 2023
The company generates no revenue, but it may be worth taking a chance on as it possesses lots of upside.
Via
The Motley Fool
Why Shares of Anavex Life Sciences Rose 12.4% in February
March 06, 2023
The company's first-quarter earnings report detailed positive news regarding its pipeline.
Via
The Motley Fool
Is Anavex Life Sciences Stock a Buy Now?
February 23, 2023
A short squeeze could be a possibility if the company can prove that bearish investors are wrong about its business.
Via
The Motley Fool
Why Anavex Life Sciences Stock Bolted Higher in January
February 08, 2023
The biotech's shares have been steadily leaking higher following positive late-stage Alzheimer's disease trial results.
Via
The Motley Fool
Anavex Life Sciences Stock Shows Improved Price Strength Rating
February 07, 2023
Anavex Life Sciences stock saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, rising from 68 to 75.
Via
Investor's Business Daily
3 Biotech Stocks Under $15 Worth a Second Look in 2023
January 18, 2023
All three stocks have promising therapies that could drive revenue in the coming years.
Via
The Motley Fool
Top Picks For 2023: Anavex Life Sciences
January 06, 2023
Anavex is a biopharmaceutical company dedicated to the development of novel drug candidates to treat central nervous system diseases, with encouraging results in Alzheimer’s, Parkinson’s, and Rett...
Via
Talk Markets
Tesla To $205? Here Are 10 Other Price Target Changes For Tuesday
January 03, 2023
Goldman Sachs cut Tesla, Inc. (NASDAQ: TSLA) price target from $235 to $205. Goldman Sachs analyst Mark Delaney maintained a Buy rating on the stock. Tesla shares fell 2.6% to $119.93 in pre-market...
Via
Benzinga
Analyzing Anavex Life Sciences's Short Interest
December 21, 2022
Anavex Life Sciences's (NASDAQ:AVXL) short percent of float has risen 17.06% since its last report. The company recently reported that it has 11.91 million shares sold short, which is 15.71% of all...
Via
Benzinga
Anavex Life Sciences Stock Could 5x Before 2025 -- Here's Why
December 17, 2022
The biotech will first need to assuage the concerns of experts by elaborating on its latest clinical trial data.
Via
The Motley Fool
Is Anavex Life Sciences a Buy?
December 13, 2022
It still needs to prove that its lead program is as effective as it claims for treating Alzheimer's.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2022
December 06, 2022
Via
Benzinga
Is Anavex Life Sciences a Smart Stock to Buy Now?
December 03, 2022
The company's Alzheimer's disease drug just succeeded in a clinical trial. Or did it?
Via
The Motley Fool
Dow Drops 100 Points; Asana Shares Plummet
December 02, 2022
U.S. stocks traded lower toward the end of trading, with the Dow Jones falling around 100 points on Friday.
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.